Literature DB >> 15284390

Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells.

Li Tang1, Yuesheng Zhang.   

Abstract

Many isothiocyanates (ITCs), some of which are abundant in cruciferous vegetables, have been repeatedly shown to inhibit carcinogenesis in a variety of rodent organs. However, several naturally occurring ITCs also promoted bladder tumorigenesis in rodents, raising the question of whether ITCs behave differently in bladder cells. Alternatively, the observed carcinogenic effects of ITCs may result from prolonged exposure of the bladder epithelium, where the tumors originate, to high concentrations of electrophilic ITCs in the urine. Ingested ITCs are almost exclusively excreted and highly concentrated in the urine as N-acetylcysteine conjugates (NAC-ITC). While several NAC-ITCs also are known anticarcinogens, they are unstable and readily dissociate into parent ITCs. In this study, ITCs, including those that have carcinogenic potential in the rodent bladders, induced apoptosis and/or arrested cell-cycle progression in 2 human bladder carcinoma lines (UM-UC-3 and T24) at 7.5-30 micromol/L. Multiple caspases, including caspase-9, -8, and -3, as well as poly(ADP-ribose)polymerase, were cleaved upon ITC exposure. The ITCs blocked cell-cycle progression at the G(2)/M and/or S phases in these cells and downregulated several cell-cycle regulators. However, further increases in ITC concentrations abolished their activities, described above. These findings show that urinary ITC concentrations may need to be maintained at low micromolar concentrations for bladder cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15284390     DOI: 10.1093/jn/134.8.2004

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  35 in total

Review 1.  The association of cruciferous vegetables intake and risk of bladder cancer: a meta-analysis.

Authors:  Ben Liu; Qiqi Mao; Yiwei Lin; Feng Zhou; Liping Xie
Journal:  World J Urol       Date:  2012-03-06       Impact factor: 4.226

2.  Proteomic analysis of covalent modifications of tubulins by isothiocyanates.

Authors:  Zhen Xiao; Lixin Mi; Fung-Lung Chung; Timothy D Veenstra
Journal:  J Nutr       Date:  2012-05-30       Impact factor: 4.798

3.  Cruciferous vegetables, isothiocyanates, and prevention of bladder cancer.

Authors:  Omkara L Veeranki; Arup Bhattacharya; Li Tang; James R Marshall; Yuesheng Zhang
Journal:  Curr Pharmacol Rep       Date:  2015-08

4.  Sulforaphane as a Promising Natural Molecule for Cancer Prevention and Treatment.

Authors:  Osama A Elkashty; Simon D Tran
Journal:  Curr Med Sci       Date:  2021-04-20

Review 5.  Cancer Biomarkers for Integrative Oncology.

Authors:  Aniruddha Ganguly; David Frank; Nagi Kumar; Yung-Chi Cheng; Edward Chu
Journal:  Curr Oncol Rep       Date:  2019-03-05       Impact factor: 5.075

Review 6.  Cruciferous Vegetables, Isothiocyanates, and Bladder Cancer Prevention.

Authors:  Besma Abbaoui; Christopher R Lucas; Ken M Riedl; Steven K Clinton; Amir Mortazavi
Journal:  Mol Nutr Food Res       Date:  2018-08-29       Impact factor: 5.914

Review 7.  The cancer chemopreventive actions of phytochemicals derived from glucosinolates.

Authors:  John D Hayes; Michael O Kelleher; Ian M Eggleston
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

8.  Inhibition of bladder cancer development by allyl isothiocyanate.

Authors:  Arup Bhattacharya; Li Tang; Yun Li; Feng Geng; Joseph D Paonessa; Shang Chiung Chen; Michael K K Wong; Yuesheng Zhang
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

Review 9.  Allyl isothiocyanate as a cancer chemopreventive phytochemical.

Authors:  Yuesheng Zhang
Journal:  Mol Nutr Food Res       Date:  2010-01       Impact factor: 5.914

10.  Breast cancer cell growth inhibition by phenethyl isothiocyanate is associated with down-regulation of oestrogen receptor-alpha36.

Authors:  Lianguo Kang; Zhao-Yi Wang
Journal:  J Cell Mol Med       Date:  2009-10-15       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.